CN107531775A - The purposes of collagen water decomposition thing and collagen water decomposition thing rich in collagen tripeptide - Google Patents
The purposes of collagen water decomposition thing and collagen water decomposition thing rich in collagen tripeptide Download PDFInfo
- Publication number
- CN107531775A CN107531775A CN201780001018.5A CN201780001018A CN107531775A CN 107531775 A CN107531775 A CN 107531775A CN 201780001018 A CN201780001018 A CN 201780001018A CN 107531775 A CN107531775 A CN 107531775A
- Authority
- CN
- China
- Prior art keywords
- collagen
- water decomposition
- decomposition thing
- thing
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 341
- 108010035532 Collagen Proteins 0.000 title claims abstract description 341
- 229920001436 collagen Polymers 0.000 title claims abstract description 341
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 240
- 238000000354 decomposition reaction Methods 0.000 title claims abstract description 209
- 210000004209 hair Anatomy 0.000 claims abstract description 86
- 102000004190 Enzymes Human genes 0.000 claims abstract description 76
- 108090000790 Enzymes Proteins 0.000 claims abstract description 76
- 239000000203 mixture Substances 0.000 claims abstract description 71
- 230000001256 tonic effect Effects 0.000 claims abstract description 38
- 239000004480 active ingredient Substances 0.000 claims abstract description 34
- 230000001737 promoting effect Effects 0.000 claims abstract description 9
- 230000000694 effects Effects 0.000 claims description 60
- 238000000034 method Methods 0.000 claims description 57
- 238000004519 manufacturing process Methods 0.000 claims description 46
- 230000001925 catabolic effect Effects 0.000 claims description 39
- 239000003795 chemical substances by application Substances 0.000 claims description 35
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 33
- 230000003656 anti-hair-loss Effects 0.000 claims description 29
- 235000013305 food Nutrition 0.000 claims description 21
- 241000251468 Actinopterygii Species 0.000 claims description 20
- 239000008194 pharmaceutical composition Substances 0.000 claims description 19
- 230000037394 skin elasticity Effects 0.000 claims description 16
- 239000011780 sodium chloride Substances 0.000 claims description 16
- 239000003814 drug Substances 0.000 claims description 13
- 239000002537 cosmetic Substances 0.000 claims description 12
- 230000006872 improvement Effects 0.000 claims description 12
- 230000003712 anti-aging effect Effects 0.000 claims description 11
- 238000004255 ion exchange chromatography Methods 0.000 claims description 11
- 244000063299 Bacillus subtilis Species 0.000 claims description 9
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 9
- 238000005277 cation exchange chromatography Methods 0.000 claims description 7
- 235000015097 nutrients Nutrition 0.000 claims description 6
- 238000005571 anion exchange chromatography Methods 0.000 claims description 5
- 229940124597 therapeutic agent Drugs 0.000 claims description 5
- 230000009759 skin aging Effects 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 230000007613 environmental effect Effects 0.000 claims description 2
- 238000011097 chromatography purification Methods 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 abstract description 22
- 201000004384 Alopecia Diseases 0.000 abstract description 17
- 230000003676 hair loss Effects 0.000 abstract description 9
- 230000001965 increasing effect Effects 0.000 abstract description 6
- 210000003491 skin Anatomy 0.000 description 104
- 229940088598 enzyme Drugs 0.000 description 72
- 230000003778 catagen phase Effects 0.000 description 30
- 108090000623 proteins and genes Proteins 0.000 description 25
- 235000018102 proteins Nutrition 0.000 description 24
- 102000004169 proteins and genes Human genes 0.000 description 24
- 230000012010 growth Effects 0.000 description 21
- 239000013641 positive control Substances 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 206010013786 Dry skin Diseases 0.000 description 17
- 239000007788 liquid Substances 0.000 description 17
- 238000010586 diagram Methods 0.000 description 16
- 230000037336 dry skin Effects 0.000 description 16
- 101100328887 Caenorhabditis elegans col-34 gene Proteins 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 15
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- 102000005158 Subtilisins Human genes 0.000 description 15
- 108010056079 Subtilisins Proteins 0.000 description 15
- 229960003957 dexamethasone Drugs 0.000 description 15
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 15
- 235000013402 health food Nutrition 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 238000010171 animal model Methods 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 229960003632 minoxidil Drugs 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- -1 dextrin Chemical class 0.000 description 10
- 210000002615 epidermis Anatomy 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 102000004363 Aquaporin 3 Human genes 0.000 description 9
- 108090000991 Aquaporin 3 Proteins 0.000 description 9
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 9
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 9
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 9
- 239000003292 glue Substances 0.000 description 9
- 210000003780 hair follicle Anatomy 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 8
- 239000004519 grease Substances 0.000 description 8
- 229960002591 hydroxyproline Drugs 0.000 description 8
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 239000000654 additive Substances 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 230000002255 enzymatic effect Effects 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 230000003020 moisturizing effect Effects 0.000 description 7
- 239000000546 pharmaceutical excipient Substances 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 6
- 108090000320 Hyaluronan Synthases Proteins 0.000 description 6
- 239000004365 Protease Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 235000013355 food flavoring agent Nutrition 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 230000036470 plasma concentration Effects 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 102000003918 Hyaluronan Synthases Human genes 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 5
- 231100000360 alopecia Toxicity 0.000 description 5
- 239000012491 analyte Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 239000007937 lozenge Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 229930002330 retinoic acid Natural products 0.000 description 5
- 210000004761 scalp Anatomy 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 229920001503 Glucan Polymers 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 238000011804 SKH1 hairless mouse Methods 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000035617 depilation Effects 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 210000004177 elastic tissue Anatomy 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 108010007119 flavourzyme Proteins 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 235000001727 glucose Nutrition 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000005374 membrane filtration Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000007493 shaping process Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 239000002033 PVDF binder Substances 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000006180 TBST buffer Substances 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 230000003402 anti-promotion Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000007767 bonding agent Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229960004039 finasteride Drugs 0.000 description 3
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000003779 hair growth Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 238000011740 C57BL/6 mouse Methods 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- OEYQBKYISMRWQB-UHFFFAOYSA-N Santal Chemical compound C=1C(OC)=CC(O)=C(C2=O)C=1OC=C2C1=CC=C(O)C(O)=C1 OEYQBKYISMRWQB-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- 201000002996 androgenic alopecia Diseases 0.000 description 2
- 229960003473 androstanolone Drugs 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003746 feather Anatomy 0.000 description 2
- 244000144992 flock Species 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 210000000442 hair follicle cell Anatomy 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 235000013550 pizza Nutrition 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 238000005199 ultracentrifugation Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- UVJWCNFWEYPYSP-SNKMQCGQSA-N 2-aminoacetic acid;(2s,4r)-4-hydroxypyrrolidine-2-carboxylic acid;(2s)-pyrrolidine-2-carboxylic acid Chemical compound NCC(O)=O.OC(=O)[C@@H]1CCCN1.O[C@H]1CN[C@H](C(O)=O)C1 UVJWCNFWEYPYSP-SNKMQCGQSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 229940113178 5 Alpha reductase inhibitor Drugs 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical class OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102000010637 Aquaporins Human genes 0.000 description 1
- 108010063290 Aquaporins Proteins 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000011547 Bouin solution Substances 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000522254 Cassia Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102100027995 Collagenase 3 Human genes 0.000 description 1
- 108050005238 Collagenase 3 Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 235000003385 Diospyros ebenum Nutrition 0.000 description 1
- 241000792913 Ebenaceae Species 0.000 description 1
- 229920001875 Ebonite Polymers 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- HVIBGVJOBJJPFB-OFQRNFBNSA-N Gly-Pro-Hyp Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)C(O)CC1 HVIBGVJOBJJPFB-OFQRNFBNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 201000009495 Hypotrichosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 101710180319 Protease 1 Proteins 0.000 description 1
- 101800001065 Protein 2B Proteins 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 244000046109 Sorghum vulgare var. nervosum Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 101710137710 Thioesterase 1/protease 1/lysophospholipase L1 Proteins 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000001548 androgenic effect Effects 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000008004 cell lysis buffer Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000010485 coping Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229960002870 gabapentin Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 108010017349 glycyl-prolyl-hydroxyproline Proteins 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000031774 hair cycle Effects 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 230000009583 hair follicle growth Effects 0.000 description 1
- 230000003660 hair regeneration Effects 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- ZWLPBLYKEWSWPD-UHFFFAOYSA-N o-toluenecarboxylic acid Natural products CC1=CC=CC=C1C(O)=O ZWLPBLYKEWSWPD-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 229940071462 oralone Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000008234 soft water Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012439 solid excipient Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000001768 subcellular fraction Anatomy 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000011269 tar Substances 0.000 description 1
- 230000003797 telogen phase Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q9/00—Preparations for removing hair or for aiding hair removal
- A61Q9/04—Depilatories
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to the purposes of a kind of collagen water decomposition thing rich in collagen tripeptide and collagen water decomposition thing, and in particular to the collagen water decomposition thing that a kind of collagen water decomposition enzyme using the special abundant collagen tripeptide of generation manufactures and the composition for promoting hair tonic and improving skin condition including the active ingredient.The collagen water decomposition thing of the present invention is compared with existing collagen water decomposition thing, and the content showed increased of collagen tripeptide, human body is preferable to its absorptivity, can effectively prevent baldness, promotes hair tonic, improves wrinkle and skin moisture-keeping etc..
Description
Technical field
This application claims in the excellent of the Korean Patent application submitted for 5 days 2 months the 10-2016-0014896th in 2016
First weigh, entire contents are incorporated herein by reference.
The present invention relates to a kind of collagen water decomposition thing rich in collagen tripeptide and collagen water decomposition thing
Purposes, and in particular to the glue that a kind of collagen water decomposition enzyme of the collagen tripeptide abundant using special generation manufactures
Former albumen water decomposition thing and the composition for promoting hair tonic and improving skin condition including the active ingredient.
Background technology
Collagen is a kind of by the dynamic of about 18 kinds of Amino acid profiles such as proline, hydroxy-proline, glycine, glutamic acid
The fibroid protein of thing, the protein of 30% special tectonic is occupied in 5000 multiple proteins for forming human body.Especially
It is that to have 70% of skin corium in substantial amounts of collagen, particularly skin in skin, bone, tendon be by collagen
Form, be the composition principal component of skin.Collagen is to be formed by various amino acid with three distortions of polypeptide combination of shape and state
Shape, molecular weight about 300000 or so, shape is very huge.
Low molecule collagen is the degraded production of the molecular weight being decomposed to form by Collagenase etc. about 5000 or so
Thing, i.e. collagen peptide.The low molecule collagen is entered after human body decomposed again by the protein decomposition enzyme in human body after
Amino acid form is ultimately formed to be absorbed by the body.Compared with the molecular weight 12000~70000 of most of protein, collagen egg
White molecular weight about 300000 or so, volume is very huge, it is difficult to absorbs.In order to be easier to digest and absorb in vivo, low point
Sub- collagen separates by extraction, is decomposed again after extractive process, be eventually converted into peptide shape of the molecular weight below 5000
State.
Collagen tripeptide is the small collagen type (molecular weight formed that is connected by 3 amino acid (glycine-X-Y)
Typically 200~500), because molecular weight is small readily permeable in skin.If the amino acid of more than 4 is connected, due to molecule knot
Structure is excessive and can not permeate in skin.Collagen tripeptide can combine immediately after passing through skin, significantly shorten and repair what is damaged
The time of collagen tissue.And after human intake inside absorptivity it is higher than low molecule collagen, collagen can be maximized
Live body effect of albumen.
Collagen is typically used as raw material with ox, pig, fish, squid etc., by obtaining collagen three after the water decomposition of enzyme
Peptide combinations.But by using protein decomposition enzyme obtain composition three peptide contents it is very low, be rich in it is difficult to obtain
The composition of tripeptides.Therefore the method for needing more effectively to refine the collagen water decomposition thing rich in tripeptides.
Hair has different growth cycles, by growth period (anagen), catagen (catagen), stand-down
(telogen) grow up and come off.These be within 3~6 years a cycle repeatedly, per day normal 50~100 hairs that come off.One
As baldness refer to that the hair in the growth stage in these cycles is less, catagen or hair in stand-down are more, make hair
Send out improper and come off.
, there are a variety of sayings the reason for alopecia, and such as androgenic effect surplus, sebum secretion is superfluous, poor circulation, mistake
Scalp hypofunction caused by oxide and bacterium etc., gene, aging, pressure etc..In alopecia reason, swash as hero
A kind of cortisol (testosteron) of element is by the dihydrotestosterone of 5α-reductase enzymatic activity
(dihydrotestosterone;DHT), the DHT is combined with specific hydrosol and is induced the protein for triggering alopecia to cause to take off
Hair.Further, since these factors trigger sebum superfluous, cause the alopecia with scalp inflammation such as acne, seborrhea.
Baldness is generally acknowledged to be due to disease, subalimentation, aging, caused by hormone is unbalanced.This was done
Many researchs, so far it has not been found that causing the basic reason of baldness.Various effort, but mesh are carried out also for hair growth disease
The medicine (Finasteride (finasteride) and minoxidil (minoxidil)) of preceding only 2 kinds of hair growths obtains U.S.
State FDA (Food and Drug Administration) official recognition.The Finasteride of 5α-reductase inhibitor is by conduct
Widely used for the hair tonic accelerator of androgenetic alopecia (androgenetic alopecia).Hypotensive agent (anti-
Hypertensive agent) minoxidil according to the opening of ATP- sensitiveness K- channels, can promote hair tonic.But the effect of medicine
Being not can also having significant limitation and is temporary transient with perfect forecast.Therefore new more effective anticreep life is needed
Hair treatment medicine.Even if to Anti-hair loss and hair tonic is promoted to have the minoxidil (minoxidil) of significant curative effect or glue at present
The medicament of polysaccharide auxin (Trichosaccharide) etc., also there is failure and the unstability to human body, and initiation allows skin
The side-effect problems such as skin allergy, therefore be badly in need of developing the composition for ensuring security and stable effect.
The content of the invention
【The technical issues that need to address】
During the related personnel of the present invention makes great efforts for collagen water decomposition thing of the manufacture rich in collagen tripeptide
It was found that the new collagen water decomposition enzyme water decomposition collagen manufactured using bacillus subtilis, can be manufactured rich in collagen
The collagen water decomposition thing of albumen tripeptides, the promotion hair tonic of the composition obtained by this water decomposition and improvement skin shape
State compares than original collagen water decomposition thing significant effect.
Therefore, it is an object of the invention to provide a kind of collagen water decomposition thing rich in collagen tripeptide, including,
(a) stage being heat-treated to the mixture of fish scale and water;(b) by centrifuging bacillus subtilis strain nutrient solution
Afterwards, the method manufacture collagen catabolic enzyme that concentration is centrifuged the filtered fluid of gained and refined using ion-exchange chromatography
Stage;(c) by the collagen catabolic enzyme input described in (a) stage mixture in after, in 25~45 DEG C of environment reclaimed water
Decompose the stage of 5~15 hours;Wherein, collagen tripeptide accounts for 20~70wt% of overall moisture solution thing.
It is an object of the invention to provide a kind of Anti-hair loss of including collagen water decomposition thing active ingredient or promote life
The food compositions of hair.
It is an object of the invention to provide a kind of Anti-hair loss of including collagen water decomposition thing active ingredient or promote life
The Pharmaceutical composition of hair.
It is an object of the invention to provide a kind of Anti-hair loss of including collagen water decomposition thing active ingredient or promote life
The cosmetic compositions of hair.
It is an object of the invention to provide a kind of the crease-resistant of including collagen water decomposition thing active ingredient, improves skin bullet
Property, anti-aging or skin moisture-keeping cosmetic compositions.
It is an object of the invention to provide a kind of the crease-resistant of including collagen water decomposition thing active ingredient, improves skin bullet
Property, anti-aging or skin moisture-keeping food compositions.
It is an object of the invention to provide a kind of collagen water for being used to manufacture Anti-hair loss or promote hair tonic therapeutic agent
The purposes of analyte.
It is an object of the invention to provide a kind of put into collagen water decomposition thing effective dose to need the individual of the composition
The method of Anti-hair loss or promotion hair tonic in body.
It is used to manufacture crease-resistant, improvement skin elasticity, anti-aging or skin moisture-keeping it is an object of the invention to provide one kind
With the purposes of the collagen water decomposition thing of agent.
It is an object of the invention to provide a kind of put into collagen water decomposition thing effective dose to need the individual of the composition
It is crease-resistant in body, improve skin elasticity, anti-aging or skin moisturization process.
【Solution】
To reach the purpose, the present invention provides a kind of collagen water decomposition thing rich in collagen tripeptide, including,
(a) stage being heat-treated to the mixture of fish scale and water;(b) by centrifuging bacillus subtilis strain nutrient solution
Afterwards, the method manufacture collagen catabolic enzyme that concentration is centrifuged the filtered fluid of gained and refined using ion-exchange chromatography
Stage;(c) by the collagen catabolic enzyme input described in (a) stage mixture in after, in 25~45 DEG C of environment reclaimed water
Decompose the stage of 5~15 hours;Wherein, collagen tripeptide accounts for 20~70wt% of overall moisture solution thing.
Present invention also offers a kind of Anti-hair loss of including collagen water decomposition thing active ingredient or promote hair tonic
Food compositions.
Present invention also offers a kind of Anti-hair loss of including collagen water decomposition thing active ingredient or promote hair tonic
Pharmaceutical composition.
Present invention also offers a kind of Anti-hair loss of including collagen water decomposition thing active ingredient or promote hair tonic
Cosmetic compositions.
Present invention also offers a kind of the crease-resistant of including collagen water decomposition thing active ingredient, improves skin elasticity, resists
Aging or the cosmetic compositions of skin moisture-keeping.
Present invention also offers a kind of the crease-resistant of including collagen water decomposition thing active ingredient, improves skin elasticity, resists
Aging or the food compositions of skin moisture-keeping.
Present invention also offers a kind of collagen water decomposition thing for being used to manufacture Anti-hair loss or promote hair tonic therapeutic agent
Purposes.
Collagen water decomposition thing effective dose is put into the individual for needing the composition present invention also offers a kind of
Anti-hair loss or the method for promoting hair tonic.
It is used to manufacture crease-resistant, improvement skin elasticity present invention also offers one kind, it is anti-aging or skin moisture-keeping agent
The purposes of collagen water decomposition thing.
Collagen water decomposition thing effective dose is put into the individual for needing the composition present invention also offers a kind of
It is crease-resistant, improve skin elasticity, anti-aging or skin moisturization process.
The present invention described further below.
The invention provides a kind of collagen water decomposition thing, including,
(a) stage being heat-treated to the mixture of fish scale and water;
(b) after by centrifuging bacillus subtilis strain nutrient solution, concentration centrifuges the filtered fluid of gained and profit
The method refined with ion-exchange chromatography manufactures the stage of collagen catabolic enzyme;
(c) by the collagen catabolic enzyme input described in (a) stage mixture in after, in 25~45 DEG C of environment
The stage of 5~15 hours of water decomposition;Wherein, collagen tripeptide accounts for 20~70wt% of overall moisture solution thing.
(a) stage is, it would be desirable to extract collagen fish scale mixed with water after high-temperature process process, be one
The collagen that fish scale is included extracts the stage in water.The fish scale and the ratio of water that (a) stage adds are without spy
Different to require, the weight ratio of preferable fish scale and water is 2 to 8.
In (a) stage from fish scale extract collagen temperature conditionss be 80~120 DEG C, preferably 85~
110 DEG C, but this temperature is not limited to, optimal temperature conditionss are according to the extraction time of collagen and the ratio of fish scale and water
Produce change.Heat treatment time in (a) stage produced change according to temperature conditionss, for 1~10 hour, preferably 2~9
Hour, it is within 3~8 hours optimal, but not limited to this.
(b) stage is the stage for preparing the water decomposition enzyme needed for water decomposition collagen, with water of the prior art
Decompose the enzyme used during collagen to compare, the especially high water decomposition thing of the content of collagen tripeptide can be manufactured, it is enzyme
Preparatory phase.The manufacture method of the present invention staff's collagen water decomposition enzyme in (b) stage by described in, is speciallyyed permit to Republic of Korea
The Room, which was submitted, applies for a patent application (application numbers:No. KR10-2015-0124453), entire contents are incorporated by reference into this
Text.
The bacterial strain that the bacillus subtilis in the present invention is deposit number KCTC12866BP, but not limited to this.
According to an embodiment of the invention, the collagen that the present invention staff includes for separation bacillus subtilis strain nutrient solution
Protease, ion-exchange chromatography is carried out under different conditions.The ion-exchange chromatography in (b) stage is available
Cation-exchange chromatography, when the concentration of sodium chloride now is 0.1~0.3M, the rate of recovery of target enzyme is optimal.Therefore, institute
When the ion-exchange chromatography for stating (b) stage is cation-exchange chromatography, preferable concentration is 0.1~0.3M chlorination
Sodium.
According to an embodiment of the invention, the ion-exchange chromatography in (b) stage can utilize anion-exchange chromatography,
When the concentration of sodium chloride now is 0.09~0.155M, the rate of recovery of target enzyme is optimal.Therefore, (b) stage from
When sub- exchange chromatography is anion-exchange chromatography, preferable concentration is 0.09~0.155M sodium chloride.
(c) stage in the present invention is the glue that the collagen extract that mixing (a) stage prepares manufactures with (b) stage
Former protease, carry out the stage of collagen water decomposition.
In embodiments of the invention, in the collagen catabolic enzyme that (b) stage manufactures under 25~45 DEG C of temperature environment
Keep the enzymatic activity of maximum duration.When temperature conditionss are more than 45 DEG C, the enzymatic activity at initial stage can with temporary increase, but with when
Between elapse, active loss is increasing, can not fully demonstrate the effect of collagen water decomposition, opposite, and temperature is less than 25
DEG C when, enzymatic activity is too low, exist can not water decomposition collagen the problems such as.
Therefore, the water decomposition temperature conditionss in (c) stage are preferably 25~45 DEG C, more preferably 27~42 DEG C, or 30
~40 DEG C are optimal.
The present invention may include that the collagen water decomposition thing obtained after (c) stage by described in, which passes through, to be centrifuged, ion
Exchange chromatography, the stage concentrated after foreign matter is removed the methods of filtering.The stage for removing foreign matter and concentrating can be led to using this area
The method often used, is not particularly limited.
The technical characteristic of the collagen water decomposition thing manufactured by the manufacture method in the present invention is, with using it
He compares at the collagen water decomposition thing of water decomposition enzyme manufacture, collagen tripeptide content showed increased.
Collagen tripeptide is that (molecular weight is general for the small collagen type that is connected by 3 amino acid (glycine-X-Y)
200~500), because molecular weight is small readily permeable in skin.If the amino acid of more than 4 is connected, due to molecular structure mistake
It can not permeate in skin greatly.Collagen tripeptide can combine immediately after passing through skin, significantly shorten the collagen repaired and damaged
The time of albumen tissue.And after intake inside absorptivity it is higher than low molecule collagen, the live body of maximizing collagen
Effect.Therefore, the content of the collagen tripeptide in collagen water decomposition thing is higher, and live body utilization rate is higher, maximizing
The physiological activity of collagen.
According to an embodiment of the invention it has been confirmed that the collagen three of the collagen water decomposition thing of the present invention
The content of peptide accounts for the about 53wt% of total moisture solution thing.Also, in the collagen water decomposition thing manufactured using other water decomposition enzymes
Substantially not including collagen tripeptides (with reference to embodiment 4 and comparative example).Collagen is difficult to be absorbed by the body in itself, therefore
Water decomposition is that small-sized tripeptides form is optimal.The collagen tripeptide being easily absorbed by the body contained in the water decomposition thing of the present invention
Content it is more apparent very high compared with the collagen water decomposition thing reported in the past the advantages of.
The collagen tripeptide specifically, the collagen water decomposition thing and whole water decomposition things in the present invention compare
Content be 20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,
43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,
68,69,70wt%.Moreover, with whole water decomposition things compare collagen tripeptide content in the range of 20~70wt% when,
It is not limited to above-mentioned numerical value.Preferably 30~70wt%, 40~70wt%, 50~70wt%, 30~60wt%, 40~
60wt%.50~60wt% is optimal, but not limited to this.
The present invention provides a kind of Anti-hair loss of including collagen water decomposition thing active ingredient or promotes the medicinal of hair tonic
Composition.
In this specification【Alopecia】For the state that the phenomenon or hypotrichosis that hair comes off from scalp attenuate;【Anticreep
Hair】To prevent and suppressing the depilation phenomenon;【Promote hair tonic】To promote the new life of hair and protecting original hair to be good for
Health.
Generally【Hair tonic】The growth stage complete, and from stand-down be converted to growth period and delay from growth period to
Catagen.The cycle of hair is broadly divided into growth stage, catagen, 3 stages of stand-down.In the growth stage with the quick increasing of cell
Grow, hair follicle grows to deep skin and forms hair.Obvious transitional period, hair follicle during this are interrupted in cell division in catagen
Gradually regression and hair tonic is stopped.It it is finally stand-down, the hair follicle of regression specifically includes dense papilla (dermal
Papilla) the plumule (germ) of cell.It is initially with the cell in the plumule in the new round growth stage phenomenon of stand-down
Fast breeding, the expansion of papilla and the synthesis of basilar memebrane key element guiding.
Therefore, it is necessary to by promoting or extending the growth stage, the loss of hair is prevented, i.e. anti-alopecia-stopping or guiding hair
Regeneration, i.e. promote hair tonic.Composition made according to the present invention includes the effect of the existing hair of solidification and anti-alopecia-stopping, adds
Thick one or more had in the improvements, and hair-growing effects such as hair.
Including compared with original water decomposition thing, hence it is evident that the collagen water of the collagen tripeptide containing very high content
The present composition of analyte active ingredient, the human body body absorption and sclerderm absorptivity of collagen can be effectively improved,
And infiltration rate is fast, to Anti-hair loss and promote hair-growing effects notable.
Specifically according to an embodiment of the invention, to the collagen water decomposition thing in the present invention and utilization this area water
Decompose what trap inside the collagen water decomposition thing of the water decomposition enzyme manufacture typically used during collagen was evaluated
As a result, the AUC of the collagen water decomposition thing in the present inventionlast,CmaxObvious very high, TmaxIt is shorter, show absorption in vivo
It is very outstanding.It may determine that the content of the collagen tripeptide of the collagen water decomposition thing in the present invention is non-according to the above
Chang Gao, therefore the very fast absorptivity of body absorption is very outstanding.
According to another embodiment of the invention, the combination containing the collagen water decomposition thing active ingredient in the present invention
Thing effectively facilitates the propagation of the hair follicle cell of the shedder sample of catagen, suppresses the progress of catagen, and has maintenance
The effect in growth period, the growth to hair have remarkable result.In addition, according to the trichogenous of the composition of the present invention
If effect and the rice ground your (Minoxidil) used as positive control group are equally very outstanding.
Collagen tripeptide content in the collagen water decomposition thing of the present invention is very high, the collagen egg absorbed in vivo
The amount of white derivative tripeptides is relatively more, and effect is also relatively good.
The present invention provides a kind of Anti-hair loss of including collagen water decomposition thing active ingredient or promotes the food of hair tonic
Composition.
These food compositions are except including the collagen water decomposition beyond the region of objective existence as active ingredient, with general food group
Compound identical includes other supplementary elements such as various flavouring agents or natural carbohydrate.The natural carbohydrate bag
Include monosaccharide, such as glucose, fructose etc.;Disaccharides, such as maltose, sucrose etc.;And polysaccharide, such as dextrin, ring paste
The glycitols such as the conventional carbohydrate and xylitol of essence etc., sorbierite, antierythrite.The flavouring agent can effectively utilize natural flavor
Agent (thaumatin), qualities of stevia extract (such as rebaudioside A, glycyrrhizin etc.) and synthesis flavouring agent (saccharin, Aspartame
Deng).
The present invention food compositions manufacture it is identical with the Pharmaceutical composition, can be used as health food or
Person is added in various food.Can add the present invention composition food such as beverage class, meat, chocolate, foodstuff,
Biscuits, Pizza, steep face, other noodles, chewing gum class, carbohydrate, ice cream, alcoholic beverage class, mix vitamin agent and
Health food etc..
And the food compositions can include various battalion except the collagen water decomposition beyond the region of objective existence as active ingredient
Support agent, vitamin, mineral matter (electrolyte) synthesis flavouring agent and natural flavours, colouring agent and sweetening agent (cheese, chalk
Power etc.), pectic acid, pectate, alginic acid, alginate organic acid, protective solid sweetening agent, PH conditioning agents, stabilize
Agent, preservative, glycerine, alcohol, soda carbonating agent etc..In addition, the composition in the present invention can include manufacture day
Right fruit juice and the pulp of fruit drink and vegetable beverage etc..
Collagen water decomposition thing as the active ingredient of the present invention is a kind of natural materials, and nontoxicity has no side effect,
Can be with Anti-hair loss, or promote the long-term use for the purpose of hair tonic.
The present invention the food compositions can be including collagen water decomposition thing active ingredient Anti-hair loss or
Promote the health food of hair tonic.
Health food in the present invention can manufacture and be processed as lozenge for the purpose of Anti-hair loss or promotion hair tonic,
The forms such as capsule, powder, granule, liquid, pill.
In the present invention【Health food】It is according to health food relevant law regulations the 6727th, is that use has to human body
The food that the functional raw material or composition of benefit are manufactured or processed, purpose are the construction and function or physiology of regulation human body
Effect etc. as health purpose acquisition beneficial effect and intake.
The health food of the present invention can include conventional food additives, be not specified by clear and definite assigned food additive
Suitability in the case of, the general provisions that are published according to the food additives of food pharmaceuticals state security department's certification and general
Experimental method etc. deserves the related specification of composition and benchmark as basis for estimation.
It is described【Food additives publish】The composition of loading is for example, ketone, glycine, calcium citrate, nicotinic acid, Chinese cassia tree
The syntheticses such as acid;The natural addition such as Perimmon element, licorice, cellulose crystallite, kaoliang color, guar gum
The mix preparation classes such as agent, Pidolidone salt pref, noodles alkaline agent, preservative, tar colorant preparation.Such as the health food of ingot shape
By admixed excipients, bonding agent, disintegrating agent and other additives in the active ingredient collagen water decomposition thing of the present invention, and
Lubricant compression forming is added after being granulated by common method or is directly compressible into mixture described in type.And according to demand in institute
State in the health food of ingot shape and add flavouring agent.
Hard rubber wafer in the health food of capsule shape is using conventional hard capsules, and by the active ingredient of the present invention
The mixture filling manufacture of the additive such as admixed excipients in collagen water decomposition thing.Soft capsule is by collagen water decomposition
The mixture of the additive such as admixed excipients is manufactured with being filled into the capsule preparations such as gel in thing.It is described soft according to demand
Matter capsule can include the additives such as the pigment agents such as glycerine or sorbierite, colouring agent, preservative.
The health food of pellet is by published manufacture method, by the active ingredient collagen water decomposition thing of the present invention
The mixture modulation shaping of middle admixed excipients, bonding agent, disintegrating agent and other additives, and according to demand using white sugar or
Other sugar-coat agent manufacture sugar-coat, or cover surface using materials such as starch, talcums.
Granular health food is by published manufacture method, by the active ingredient collagen water decomposition of the present invention
The mixture modulation of admixed excipients in thing, bonding agent, disintegrating agent and other additives granulates, and according to demand, can be with
Including additives such as flavouring agent, flavor enhancements.
The health food can be beverage class, meat, chocolate, foodstuff, Biscuits, Pizza, steep face, other faces
Class, chewing gum class, carbohydrate, ice cream, alcoholic beverage class, mix vitamin agent and health food etc..
The present invention provides a kind of Anti-hair loss of including collagen water decomposition thing active ingredient or promotes the medicinal of hair tonic
Composition.
According to the present invention Pharmaceutical composition, can individually include the present invention in collagen water decomposition thing or can be with volume
Include more than one pharmaceutical carrier, excipient or diluent outside.
Pharmaceutical carrier can comprise additionally in oral carrier or parenteral carrier.Oral carrier can include lactose, and starch is fine
Tie up plain conductor, magnesium stearate, stearic acid etc..And parenteral carrier can include water, appropriate oil, normal saline solution, water solubility
Glucose and glycol etc., and can additionally include stabilizer and preservative.Suitable stabilizer has sodium hydrogensulfite, sulphur
The antioxidants such as sour sodium or ascorbic acid.Suitable preservative has chlorination benzalkonium chloride, methyl or P-hydroxybenzoic acid third
Ester and methaform etc..In addition documents below contents (Remington's can be referred to as the medicinal carrier used
PHarmaceutical Sciences,19th ed.,Mack Publishing Company,Easton,PA,1995)。
Any input method can be used to put into the mammal including the mankind for the Pharmaceutical composition of the present invention.It is such as oral
Or parenteral input.Parenteral investing method has intravenously, intramuscular, intra-arterial, in marrow, in pleura, and sclerderm in heart,
Subcutaneously, intraperitoneal, in nasal cavity, intestinal tube is local, is put into sublingual or rectum, but not limited to this.Preferably orally put into this hair
Bright Pharmaceutical composition.For example, the Pharmaceutical composition of the present invention is modulated into injection-type preparation, and use the injection needle of 30 gauges
Gently puncture the method for skin or be applied directly to the method for skin surface and put into.
The Pharmaceutical composition of the present invention such as content, for oral use or parenteral system can be divided according to input approach
Agent is molded.
Composition of the invention for preparations for oral administration can be powder, granule, lozenge, pill, sugar-coat lozenge, capsule
Agent, liquid agent, gel, syrup, agent, suspension etc. is starched, pass through manufacture method modulation shaping disclosed in this area.For example,
For oral use dose active component and solid excipient are allocated after crush, then add appropriate adjuvant post-processing as particle mixing
Thing, obtain lozenge or sugar-coat lozenge.Suitable excipient has including lactose, glucose, sucrose, sorbierite, mannitol, xylose
The carbohydrate of alcohol, antierythrite, maltitol etc.;Include the starch of cornstarch, wheaten starch, rice starch, potato starch etc.
Class;Include the cellulose family of cellulose, methylcellulose, sodium carboxymethylcellulose, hydroxypropyl methyl cellulose etc.;Including solidifying
The filler of glue, polyvinylpyrrolidone etc..The Pharmaceutical composition of the further present invention, which adds, includes anti-coagulants, lubricant,
Spices, emulsifying agent and preservative etc..
For preparations for oral administration, with injection, creams agent, emulsion agent, externally-applied soft ointment, essential oil agent, NMF, gel
The forms such as agent, spray and snuff, pass through manufacture method modulation shaping disclosed in this area.These forms are all remembered
Be loaded in prescription document disclosed in pharmaceutical chemistry (Remington's PHarmaceutical Science, 15th Edition,
1975.Mack Publishing Company,Easton,Pennsylvania 18042,Chapter 87:Blaug,
Seymour in).
The Pharmaceutical composition of the present invention as external preparation for skin Pharmaceutical composition in use, as Anti-hair loss, promotion hair tonic with
And improve the skin preparations for extenal use of scalp state, with creams, gel, sticking patch, spray, ointment, emplastrum, emulsion agent, smear
The Pharmaceutical composition modulation shaping of the skin preparations for extenal use form of agent, paste or opoultice, but it is not limited to this.
Total effective dose of the Pharmaceutical composition of the present invention puts into patient as single input amount (single dose), also may be used
Classification therapeutic scheme (fractionated to put into patient for a long time as multiple input amount (multiple dose)
treatment protocol).The Pharmaceutical composition of the present invention according to the weight of the state of an illness, can adjust the content of active ingredient.
Preferably, divided according to the glycoprotein of the present invention, the every overall dosage not daily 1kg of body weight of daily patient is about 0.01ug
~1,000mg, or 0.1 μ g~100mg are optimal.But the dosage of the therapeutic agent candidate substances of the invention is, it is necessary to examine
Consider the input approach and treatment number of times of Pharmaceutical composition, and be also contemplated that the age of patient, body weight, health status, sex,
The many factors such as the weight of symptom, eating habit and drainage status determine effective input amount to patient.For this area skill
For art personnel, the specific use using the Pharmaceutical composition of the invention as Anti-hair loss and the pharmaceutical formulation for promoting hair tonic
On the way, appropriate adjustment is made to effective input amount.For the shape of the Pharmaceutical composition of the present invention, approach and input side are put into
Method can be adjusted flexibly.
The present invention provides a kind of Anti-hair loss of including collagen water decomposition thing active ingredient or promotes the beauty of hair tonic
Use composition.
According to the cosmetic compositions of the present invention, the active ingredient except including the collagen water decomposition thing in the present invention
Outside, in addition to it is usually used in the compositions of cosmetic compositions.Such as including antioxidant, stabilizer, solubilizer, vitamin, pigment
And the usual auxiliaries and carrier of dyestuff etc..
Moreover, do not damaging collagen water in addition to the collagen water decomposition thing in the composition of the present invention
In the case of the Anti-hair loss of analyte and the effect of promotion hair tonic, can be mixed with existing Anti-hair loss agent and preparation for baldness makes
With.
Moreover, the cosmetic compositions of the present invention can be modulated into the arbitrary shape for deserving industry universal.For example, hair tonic
Oil, hair conditioner, hair-care essence liquid, hair care breast, nutritional breast of defending the doctrine, shampoo, irrigation , treatment waxes of taking care of hair, Hair-conditioning essential oil, hair care
Frost, nourishing cream of taking care of hair, moisturizing breast of defending the doctrine, scalp massage frost, pomade, hair sprays, send out film, nutrient hair mask, hair soap, hair washing
Breast, foam of having one's hair wash, hair oil, hair drier, agent for treatment of hair, hair dye, agent for permanent hair waving, decolorising agent, hair styling gel, hair elite
The form that breast, hair cosmetic agent, hair care spraying, hair moisturiser, hair cream, hair jelly etc. all aoxidize, but not limited to this.
According to an embodiment of the invention, collagen water decomposition thing of the invention improves skin to the crease-resistant of skin, moisturizing etc.
Skin state aspect has significant effect.The collagen water decomposition thing manufactured by the collagen water decomposition enzyme of the present invention
The excellent for the collagen water decomposition thing that skin condition improvement substantially manufactures than existing collagen water decomposition enzyme.
Judge that the collagen water decomposition thing in the present invention is rich in collagen tripeptide with this, it is higher to human body utilization rate, and collagen
The physiologically active of albumen plays more preferable.
It can clearly confirm the collagen water decomposition thing in the present invention to skin condition by crossing specific embodiment
Improvement.
The present invention provides a kind of anti-including the crease-resistant of the collagen water decomposition thing active ingredient, improvement skin elasticity
Aging or the cosmetic compositions of skin moisture-keeping.
In addition the present invention provides a kind of including the crease-resistant of the collagen water decomposition thing active ingredient, improves skin bullet
Property, anti-aging or skin moisture-keeping food compositions.
Foregoing content can be all suitable for the cosmetic compositions and food compositions.
The present invention provides a kind of collagen water decomposition thing for being used to modulate Anti-hair loss or promote hair tonic therapeutic agent
Purposes.
The present invention provides a kind of anticreep for putting into collagen water decomposition thing effective dose in the individual for needing the composition
Hair or the method for promoting hair tonic.
Present invention offer is a kind of crease-resistant for modulating, improvement skin elasticity, described in anti-aging or skin moisture-keeping agent
The purposes of collagen water decomposition thing.
The present invention provide it is a kind of collagen water decomposition thing effective dose is put into it is crease-resistant in the individual for needing the composition,
Improve skin elasticity, anti-aging or skin moisturization process.
It is described in the present invention【Effective dose】When putting into individual, to promote hair tonic and improvement, treatment, pre- anticreep
The amount of hair and other effects, and improve, treatment, prevention wrinkle of skin, skin elasticity, the amount of skin aging and skin moisturization;
It is described【Individual】Extracted for animal, preferably mammal, the particularly animal including the mankind or from animal thin
Born of the same parents, tissue, organ etc..The individual can also be the patient for needing the effect.
【The technique effect of invention】
The present invention relates to a kind of collagen water decomposition thing rich in collagen tripeptide and collagen water decomposition thing
Purposes, collagen water decomposition thing of the invention compared with existing collagen water decomposition thing, collagen tripeptide
Content showed increased, human body are preferable to its absorptivity, can effectively prevent baldness, promote hair tonic, improve wrinkle and skin is protected
It is wet etc..
Brief description of the drawings
Fig. 1 is to utilize point of the cationic ion resin of the collagen catabolic enzyme manufactured by embodiments of the invention
From the figure for refining result.A is the SDS-PAGE analysis results (M of the collagen catabolic enzyme of refinement:The big tick marks of protein,
conc:Concentrating sample, wash:Clean, E1~E5:Elution samples 1~5).B is, according to the buffer concentration in AKTA primer
The collagen catabolic enzyme extractive process not changed is identified as maximum (arrow is respectively the mark of elution samples).
Fig. 2 is to utilize point of the anionic ion resin of the collagen catabolic enzyme manufactured by embodiments of the invention
From the figure for refining result.A is the SDS-PAGE analysis results (M of the collagen catabolic enzyme of refinement:The big tick marks of protein,
P1:Represent peak 1).B is the collagen catabolic enzyme extractive process mark not changed according to buffer concentration in AKTA primer
Know for maximum (arrow is respectively the mark of elution samples).
Fig. 3 is temperature and the enzymatic activity result schematic diagram of the collagen catabolic enzyme manufactured by embodiments of the invention
Table.
Fig. 4 is the enzyme elapsed according to time and temperature of the collagen catabolic enzyme manufactured by embodiments of the invention
Activity change result schematic diagram table.
Fig. 5 is PH and the enzymatic activity result schematic diagram table of the collagen catabolic enzyme manufactured by embodiments of the invention.
Fig. 6 is to pass through the collagen of the collagen catabolic enzyme that embodiments of the invention manufacture and general protein decomposition enzyme
HPLC data (the A of albumen tripeptides productivity contrast:CTP standard substances, B:Collagen catabolic enzyme BP, C:Alkali protease
Alcalase 2.4L FG,D:Flavor protease Flavourzyme 1000L, E:Papain Collupulin MG).
Fig. 7 is that, using the collagen catabolic enzyme manufactured by embodiments of the invention, production is rich in collagen tripeptide
Collagen water decomposition thing manufacturing process's schematic diagram.
Fig. 8 is the glue in the water decomposition thing produced using the collagen catabolic enzyme manufactured by embodiments of the invention
HPLC data (the A of former albumen tripeptides (CTP) content analysis:CTP standard substances, B:Collagen catabolic enzyme BP, C:Basic protein
Enzyme Alcalase 2.4L FG).
Fig. 9 is to put into experiment to the animal experiment body that catagen depilation is induced using dexamethasone (Dexamethasone)
During material, the growth period of hair follicle and effect assessment results icon ((A) defeathering the 9th day, (B) defeathering of catagen ratio are influenceed
11st day, (C) defeathering the 14th day, (D) defeathering the 17th day, anagen:Growth stage, catagen:Catagen, Nor:It is not used, ground
Sai meter Song processing, the normal group of a defeathering, Control:Handled using dexamethasone and the solvent control of solvent is put into after defeathering
Group, BP-CH:Handled using dexamethasone and the group of the collagen water decomposition thing of the present invention, Minox are put into after defeathering:Use
The positive control group of minoxidil is put into after dexamethasone processing and defeathering).
Figure 10 is, dynamic to testing after the animal experiment body input substances lost hair or feathers using Induced By Dexamethasone catagen
The influence result schematic diagram that the body hair growth of thing is brought.
Figure 11 is to be observed by tissue staining body, the skin of the animal experiment body to be lost hair or feathers using Induced By Dexamethasone catagen
Result schematic diagram (the Dex of skin tissue hair follicle growth:Dexamethasone).
Figure 12 is to be irradiated by UV after inducing wrinkle and putting into each material, use silica gel and the woods mould of epoxy resin
Result figure (the N of plate observation:Normally, C:Control, P:Positive control, COL17, COL34:Pass through in general collagen catabolic enzyme
Collagen water decomposition the thing 17mg/kg or 34mg/kg of production input group, CTP17, CTP34:The collagen of the present invention
Water decomposition thing 17mg/kg or 34mg/kg input group).
Figure 13 is, after experiment just terminates, gathers the skin of the hairless mouse of SKH-1, carries out the result of horse pine trichrome staining
Schematic diagram (N:Normally, C:Control, P:Positive control, COL17, COL34:The glue produced by general collagen catabolic enzyme
Former albumen water decomposition thing 17mg/kg or 34mg/kg input group, CTP17, CTP34:The collagen water decomposition thing of the present invention
17mg/kg or 34mg/kg input group).
Figure 14 is, after experiment just terminates, gathers the skin of the hairless mouse of SKH-1, passes through immune-blotting method method confirmation group
Knit the quantized result schematic diagram (N of interior collagen 1A (A) and MMP-1 (B) protein discovery amount:Normally, C:Control, P:
Positive control, COL17, COL34:By in general collagen catabolic enzyme produce collagen water decomposition thing 17mg/kg or
Person 34mg/kg input group, CTP17, CTP34:Collagen water decomposition the thing 17mg/kg or 34mg/kg of the present invention throwing
Enter group).
Figure 15 is, when the 5th week interstage of experiment and the 10th week, confirms the grease (A) of mouse skin, moisture (B)
Result schematic diagram (the N of state:Normally, C:Control, P:Positive control, l, COL17, COL34:Pass through in general collagen point
Solve collagen water decomposition the thing 17mg/kg or 34mg/kg of enzyme production input group, CTP17, CTP34:The collagen of the present invention
Albumen water decomposition thing 17mg/kg or 34mg/kg input group).
Figure 16 is, after putting into each material to the Balb-c mouse for inducing dry skin, evaluates the knot of skin moisture content
Fruit schemes (N:Normally, C:Control, P:Positive control, COL17:Collagen water decomposition the thing 17mg/kg, COL34 of the present invention:It is logical
Cross the collagen water decomposition thing 34mg/kg of in general collagen catabolic enzyme production input group).
Figure 17 is, after putting into each material to the Balb-c mouse for inducing dry skin, what is tickled by pruitus is secondary
Number measurement result schematic diagram (N:Normally, C:Control, P:Positive control, COL17:The collagen water decomposition thing 17mg/ of the present invention
Kg, COL34:The collagen water decomposition thing 34mg/kg produced by general collagen catabolic enzyme input group).
Figure 18 is, each material is put into the Balb-c mouse for inducing dry skin, and gathers after off-test each old
Mouse skin histology, the quantized result schematic diagram (A of skin moisture-keeping factor protein matter discovery amount is confirmed by immune-blotting method method:
Collagen 1A, B:AQP3, C:HAS2, N:Normally, C:Control, P:Positive control, control), COL17:The glue of the present invention
Former albumen water decomposition thing 17mg/kg, COL34:The collagen water decomposition thing produced by general collagen catabolic enzyme
34mg/kg input group).
Embodiment
Embodiments of the invention described further below.
Following examples are only the example of the present invention, and present disclosure is not limited to following examples.
<Embodiment 1>
The manufacture of collagen water decomposition enzyme
The manufacture method of collagen water decomposition thing in the present invention and the collagen water manufactured by methods described
Analyte related content is with reference to korean patent application the 10-2014-0158019th.
That is, mTB medium (the yeast extract2.4%, tryptone1.2%, glycerol 1% of 100ml
KH2PO42.31%, H2HPO412.54%) in after culture bacillus subtilis strain (deposit number KCTC12866BP)
Centrifuged 15 minutes in 6500rpm.Filtered fluid is transferred to after new flexible pipe and is concentrated into 5 times using 30kDa filter.Make
With AKTA prime equipment, by ion-exchange chromatography, the filtered fluid after concentration is refined.
Refinement condition now is that A is buffered into (50mM Tris-HCl (pH7.5)) buffers use as binding, and
(50mM Tris-HCl (pH7.5), 0.5M NaCl) is buffered using B to tilt, and flow velocity is 5ml/min.Refinement uses cation
Exchange chromatography and anion-exchange chromatography, ion exchange resin use resin cation SP sepHarose resin respectively
(GE Healthcare, new-Jersey, USA) and resin anion (R.A.) Q sepHarosse resin (GE healthcar,
New-Jersey, USA).
0.5M NaCl inclinations are set in cation-exchange chromatography first, and protein is refined according to each division.Such as figure
Shown in 1B, confirm in SDS-PAGE, refine the protein refinement degree that protein maximum division (E1~E5) is shown in chart, hair
Protein containing prediction target enzyme in existing E1, E2, particularly can confirm that in E1 and is decomposed containing substantial amounts of collagen
Enzyme (Figure 1A arrow represents).
E1~E5 NaCl concentration is E1:0.1~0.2M, E2:0.2~0.3M, E3:0.3~0.4M, E4:0.4~
0.5M, E5:0.5M.It is possible thereby to learn, by cation-exchange chromatography separate the NaCl concentration of target enzyme for 0.1~
0.3M.Preferably, the rate of recovery of target enzyme is optimal in the case of the 0.1~0.2M of NaCl concentration of E1 parts.Then, by the moon from
Sub- exchange chromatography refines E1.
The buffering now used is 0.25M NaCl, and sets identical gradient with cation-exchange chromatography.Such as figure
Shown in 2B, when the anion exchange resin refined in chart is 0.09~0.115M NaCl, there is the maximum (figure of protein
2B arrow represents).
The refinement figure that should be divided is confirmed from SDS-PAGE, can confirm that most of target enzyme has refined clean (figure
2A P1).It is possible thereby to learn, NaCl concentration is target in the case of 0.09~0.155M when passing through anion-exchange chromatography
The rate of recovery of enzyme is optimal.The new collagen protease extracted is named as BP below.
<Embodiment 2>
BP enzyme reaction condition test
Tested as optimum temperature, carry out enzyme reaction in 20~70 DEG C of temperature, and measure potency.As shown in figure 3, temperature
For 0~55 DEG C when, produce enzymatic activity, the specific activity (specific of peak particularly shown in the environment of 50 DEG C
Activity) and relative activity (relative activity), activity drastically declines since 60 DEG C of temperature.
Suitable for a large amount of productions, to be tested the stabilisation of temperature.Temperature is adjusted to 30 DEG C, 35 DEG C, 40 DEG C with
And 50 DEG C, and the other sample of each temperature was not sampled from the time of 0~12 hour and confirms respective residual activity.
As shown in figure 4, the lower enzyme of temperature shows more continual and steady state, it is small by 12 between 35 DEG C~40 DEG C
When after remain about 59.3% activity.As can be seen here, it is optimal the production process temperature of collagen tripeptide to be adjusted into 35 DEG C.
Next optimal pH value is confirmed.By pigskin, gel, matrix is not respectively put into buffering (50mM according to pH value
citrate-Na2HPO4(pH5.0~6.0), 50mM Tris-HCl (pH6.0~9.0), 50mM Na2CO3-Na2HCO3(pH9.0
~10.0) activity of enzyme is determined after melting in) and confirms optimal pH.Highest activity is presented in BP in the environment of pH 7.4,
Higher activity is presented under pH 6~10 differential gap environment.But as shown in figure 5, it can confirm that slant acidity or meta-alkalescence
In the case of enzyme reduced activity.
The process using the collagen catabolic enzyme (BP) manufacture collagen tripeptide is illustrated below.
<Embodiment 3>
Confirm BP collagen tripeptide prouctiveness
The fish scale of pretreatment is put into the reactor set in mixer.According to 20:80 weight ratio equably mixes
Fish scale and water, and about 90 DEG C of temperature be heat-treated 5 hours after, prepare 4 samples.4 samples use collagen respectively
Catabolic enzyme (BP) (manufacturer:Amicogen), alkali protease 2.4L FG (Alcalase 2.4L FG) (manufacturer:
Novozyme, dealer:Viosys), flavor protease 1 (Flavourzyme 1), 000L (manufacturer:Novozyme, sell
Business:Viosys), papain MG (Collupulin) (manufacturer:Novozyme, dealer:Great bell business) enzyme, compare
The prouctiveness of collagen tripeptide.
The reaction condition of each enzyme is following (temperature, PH, enzyme usage amount, reaction time).
-BP:35 DEG C, pH 7.4,30unit/g (fish scale), 12 hours
-Alcalase 2.4L FG:60 DEG C, pH 7.0,30unit/g (fish scale), 12 hours
- Flavourzyme 1,000L:55 DEG C, pH 6.0,30unit/g (fish scale), 12 hours
-Collupulin MG:60 DEG C, pH 7.0,30unit/g (fish scale), 12 hours
After ferment treatment, the heat treatment carried out 30 minutes under 80 DEG C of temperature environment is deactivated, also, 4 kinds of enzymes are carried out
Comparative analysis, confirm the line balancing rate of BP collagen tripeptide.
The collagen water decomposition thing to manufacture is analyzed using HPLC (gilson, Gilson Inc).In SuperdexTM
Peptide10/300GL posts, mobile phase (10mM Tris-Cl (pH7.4), 0.15M NaCl, 5mM CaCl2), flow velocity:
0.5ml/min condition is in analysis collagen tripeptide (collagen tripeptide, CTP).CTP standard substance uses
By the Gly-Pro-Hyp (glycine-proline-hydroxyproline, GPH) of 3 kinds of Amino acid profiles.
As shown in fig. 6, CTP standard substances shown in analysis result formed maximum at about 55 minutes or so.Compare 4 kinds of enzymes
Degrading activity is it is known that, collagen later using the ratio of the maximum formation of the collagen water decomposition thing of BP progress water decompositions
Albumen is degraded.And standard substance shows larger maximum in the same period, CTP content can be learnt very
It is high.Using the collagen water decomposition thing and other of Alcalase 2.4L FG water decompositions using Flavourzyme 1000L or
The collagen water decomposition thing of the person's collupuin MG water decompositions low molecule content that compares is very high, but CTP contents almost do not have
Have.It is possible thereby to learn that the production effects of BP to collagen tripeptide are notable.
<Embodiment 4>
Use the manufacture of BP collagen water decomposition thing
In order to manufacture the collagen water decomposition thing containing collagen tripeptide, the manufacture method using BP is established.
The fish scale of pretreatment is put into the reactor set in mixer.According to 20:80 weight ratio equably mixes
Fish scale and water, and be heat-treated 5 hours in about 90 DEG C of temperature.
Under 35 DEG C of temperature environment, the liquid after heat treatment is put into 10%NaOH, adjusts the pH of solution
Maintain 7.4.The BP of about 30unit/g (fish scale) left and right is put into the liquid after adjustment, and under 35 DEG C of temperature environment
Reaction 12 hours.After ferment treatment, the heat treatment carried out 30 minutes under 80 DEG C of temperature environment is deactivated.Use ultracentrifugation
After the foreign matter in collagen tripeptide liquid after separator removal ferment treatment, pass through ion column and remove the foreign matters such as metal ion.
Using vacuum pump-down thickener, after the liquid concentration to Brix 35%, by active carbon purifying, taken off
Color removes peculiar smell.By the secondary filter of active carbon purifying liquid (membrane filtration, membrane filtration), it is carried out it is degerming after, make
With spray dryer powdered, and Quality Detection is carried out, by packing stage, produce the collagen water decomposition rich in tripeptides
Thing (Fig. 7)
<Comparative example 1>
Use the manufacture of the collagen water decomposition thing of general water decomposition enzyme
In order to compared with the manufacturing process using new BP, using being used in general low molecule collagen decomposition process
Alcalase 2.4L FG (manufacturers:Novozyme, dealer:Viosys the line balancing rate of collagen tripeptide) is compared.
The fish scale of pretreatment is put into the reactor set in mixer.According to 20:80 weight ratio equably mixes
Fish scale and water, and about 90 DEG C of temperature be heat-treated 5 hours.
Under 35 DEG C of temperature environment, the liquid after heat treatment is put into 10%NaOH, adjusts the pH of solution
Maintain 7.5.The Alcalase enzymes of about 30unit/g (fish scale) left and right are put into the liquid after adjustment, and in 35 DEG C of temperature
Reacted 12 hours under degree environment.After ferment treatment, the heat treatment carried out 30 minutes under 80 DEG C of temperature environment is deactivated.
After the foreign matter in the collagen tripeptide liquid after ferment treatment is removed using ultracentrifugation separator, pass through ion column
Remove the foreign matters such as metal ion.Using vacuum pump-down thickener, after the liquid concentration to Brix 35%, pass through activated carbon
Purification, carries out colour fading and removes peculiar smell.Active carbon purifying liquid is passed through into filter press filtering or secondary filter (membrane filtration, membrane
Filtration), it is carried out it is degerming after, using spray dryer powdered, and after carrying out Quality Detection, collagen is carried out to it
Albumen tripeptides (CTP) content analysis.
CTP content analysis is carried out with the identical method of embodiment 2.The final tune manufactured using BP and Alcalase
Collagen water decomposition thing with previous stage is analyzed.
As shown in figure 8, on CTP contents it is known that using the collagen water decomposition thing that BP is manufactured and CTP reference materials
The maximum of matter shows that position is identical, but is not shown on same position using the Alcalase collagen water decomposition things manufactured
Maximum.
To be using the CTP content quantitative result of the comparison of the collagen water decomposition thing of BP and Alcalase manufactures, BP
53.1%, but Alcalase is 0%.It is possible thereby to learn, the collagen rich in collagen tripeptide can be manufactured using BP
Water decomposition thing.
<Embodiment 5>
Collagen water decomposition thing using BP is compared with the trap of the collagen water decomposition thing using Alcalase
<5-1>Animal test method
Ether anesthesia male mouse, after being inserted at its right carotid artery with polyethylene pipe, using transfusion back strap by sleeve pipe from
Extracted out by place, and adjust its position, allow suture mouth after the free activity of rat.Mouse fasting 12 hours to intubation with
On, it is only supplied drinking water.6 are selected in each group respectively, according to the collagen water decomposition of the embodiment 4 and comparative example 1
The collagen water decomposition thing (BP-CH) using BP and the collagen moisture using Alcalase of thing manufacture method manufacture
Solution thing (Alcalase-CH) is dissolved in distilled water and put into 500mg/kg (5mL/kg) capacity respectively.After input on a time period
(15,30,45,60,90,120,180,240 and 360 points) use centrifugal separation technology separation bleeding after arteria carotis blood sampling
Slurry.The blood plasma isolated freezen protective under -20 DEG C of temperature environment, while analyze the hydroxyproline in blood plasma with LC-MS/MS
The concentration of (Hydroxyproline, Hyp) is simultaneously quantitative.
<5-2>LC-MS/MS analytic approach
Sample pretreatment:After internal standard liquid (the μ g/mL of Gabapentin 0.1) mixing is added in 50 μ L blood plasma, then add
After adding the μ L of trichloroacetic acid 50 of 5% concentration to mix, filtered fluid is obtained after 13000rpm is centrifuged 10 minutes.Filtered fluid is dilute
After releasing 2 times, take out in 2 μ L injections LC-MS/MS and analyzed
Analytical equipment:Agilent1260HPLC system and Agilent6460triple-quadrupole mass
spectrometer
Post:Zorbax SB-Aq, particle size 1.8 μ, 2.0mm, i.d. × 100mm, l.
Column temperature:30℃
Mobile phase:0.1% formic acid (A) acetonitrile (B) gradient elution
Flow velocity:0.25mL/min
Injection rate:2μL
<5-3>Trap evaluation method
After formulating the plasma concentration v. time curve for each target component of each group, plasma concentration v. time curve is sought
The gross area (AUC;Area under the plasma concentration-time curve), with this comparison trap.AUC
Pass through linear trapezoid method (linear trapezoidal method) value of quadraturing.Extrapolation is relatively difficult in terminal phase, therefore not
Need the unlimited AUC for seeking total AUC, asking untill 6 hours of final blood sampling pointlast.Maximum plasma concentration (Cmax) and maximum plasma
Concentration arrival time (Tmax) directly can read in the graph.AUC, C between each group is analyzed by one-way ANOVAmax,
TmaxNumerical value, and pass through Duncan conspicuousnesses on proof method Research statistics afterwards.
<5-4>The mounting test result of collagen water decomposition thing
The ACU values and cmax value of free hydroxyproline, the conspicuousness between BP-CH and Alcalase-CH groups are poor in blood
It is different.This is to illustrate that the hydroxyproline absorptivity in blood is higher.Moreover, the Tmax values and Alcalase- of input BP-CP group
CH faciations are than very fast.It is possible thereby to learn, hydroxyproline is absorbed rapidly after BP-CH is absorbed, and stay in blood
Time is shorter, may infer that from the soak time from blood to tissue and accelerates (table 1).
It is known that can be true in change passage in the blood of the special acid hydroxyproline of collagen by this experiment
Recognize, the sink effect using BP collagen water decomposition thing is substantially higher than using Alcalase collagen water decomposition thing.
【Table 1】
The hydroxyproline of collagen water decomposition thing using BP and the collagen water decomposition thing using Alcalase
Trap results contrast
Abbreviation:
AUClast, from the gross area that the time is zero plasma concentration time curve of time of measuring to the end, 6 hours;Cmax,
Peak plasma concentration;Tmax, reach Cmax time;
aSD:Standard deviation;
b:CTP groups and the significant difference (p of Alcalase-CP groups<0.05).
c:TmaxIntermediate value (scope)
<Embodiment 6>
Use the Anti-hair loss and promotion hair-growing effects of BP collagen water decomposition thing
<6-1>Experimental animal food manufactures
Collagen water decomposition thing, BP enzymes are manufactured with the collagen water decomposition manufacture method identical method of embodiment 4
Treating capacity with 17unit/g processing, produce collagen water decomposition thing of the CTP contents 28% or so, used for edible
On the way.
<6-2>The establishment of experimental animal and catagen shedder sample
Experimental animal is C57BL/6 mouse.Due to melanin in the hair follicle of the species be present, and according to the amount skin of melanin
The colour of skin can produce change, therefore (growth period hair cycle can be judged according to the colour of skin:Black, catagen and stand-down:It is pink
Color).Initially enter stand-down within 6~7 weeks after life.Because of this characteristic, the animal is selected as test body, and 35 are introduced from DBL (loyal north)
The C57BL/6 Female Rats (17g-20g) of 6 weeks after only giving birth to.
Trial flock be respectively set as using Induced By Dexamethasone catagen dexamethasone processing group, dexamethasone processing with
And verification albumen water decomposition thing (BP-CH) the input group using BP manufactures, solvent control group (control) and positive control group
(3% minoxidil) processing group etc..Each group has 8 mouse to form.When putting into solvent control group and collagen water decomposition thing
Body weight is measured, and is put into 2,000mg/10ml/kg input amounts continuous oral one time a day, positive control group also smears rice daily
Promise ground you.
Using animal with mao device or hair remover is pushed away, will be used rapidly after the back hair removing of the experimental animal of 7 weeks after life
Water cleans.Test sample of input and minoxidil are continuously put into 10 days defeathering daily from 7th day.Defeathering connects from the 9th day
Continuous 5 days 0.1% dexamethasone for smearing 1ml at the back of experimental animal daily.Experimental animal is in final sample test and rice
Promise you input after ether anesthesia death in the 2nd day.
<6-3>Suppress depilation catagen and maintain growth period effect to confirm
Daily clinical symptoms for confirming experimental animal and whether dead.In order to visually confirm the guiding effect in growth period
Fruit, a film,fault is clapped weekly, in order to observe the effect for suppressing catagen, clap a film,fault within every 3 days.Photo after shooting utilizes
Color in the overall defeathering position of ImageJ determination test animals is by the changing ratio of ash to black, long-term and regression of seeking survival
The ratio of phase
The result of experiment is illustrated in table 2 below, Fig. 9 and Figure 10 above.
【Table 2】
Suppress the catagen ratio (%) in the defeathering position of catagen test body
Above-mentioned numerical value is average value ± SE.
The significant difference of the control group of Dunnet's tests:* p < 0.01.
The numerical value of the table is the catagen progress ratio at the position that defeathering induces catagen.That is, the higher catagen of ratio
Progression rates are high, and ratio is lower, just represent and successfully suppress catagen.The BP-CH marked in the table is the collagen for absorbing the present invention
The fauna of albumen water decomposition thing.
Shown in the table 2, Figure 10 and Figure 11, the ratio of the defeathering growth period of the 9th day and catagen is shown, normal right
According to group and substances input group without too big difference, but minoxidil smears group and only makees the solvent of dexamethasone processing
Control group is compared, and statistically shows that growth stage ratio is higher, and catagen ratio is reduced.±
Defeathering the 11st day, 14 days, the back pinkiness for starting solvent control group on the 17th, untill off-test always
Keep catagen.The defeathering growth stage ratio that substances input group and minoxidil smear group from the 11st day statistically has
Obvious increase.
<6-3>Tissue detection
According to the embodiment<5-1>After being tested, the defeathering position of experimental animal is gathered, observes hair follicle state.
That is, experimental animal is excessively anaesthetized it is lethal after, dermal tissue harvesting keeping 10% concentration neutral formalin
In solution, after FFPE, histotomy is made with the section of 5 μ m thicks, and use hematoxylin eosin staining.
It is as shown in figure 11 to deserve result.
As shown in figure 11, it is thinning to carry out the epidermis for the solvent control group that dexamethasone processing induces catagen, is not formed
Hair follicle.The epidermis for the group (BP-CH) for absorbing collagen water decomposition thing after dexamethasone processing is thickening, and hair follicle is flourishing and is molded.
It is also that can confirm that the thickening hair follicle of epidermis is flourishing that minoxidil, which smears group,.
That is, collagen water decomposition thing of the invention promotes propagation and the raising of hair follicle cell under catagen depilation state
The growth result of hair is notable.
<Embodiment 7>
Use the improvement wrinkle effect of BP collagen water decomposition thing
After the life for the SKH-1 hairless mouses system that this experiment uses 6 weeks sample (female) be from SAMTAKO BIO KOREA
After (Ebony Hill city of Gyeonggi, South Korea) adopts, in southeast medical chemistry research institute animal house (animal facility registration card:No. 412) enter
The one-week quarantine of row and the healthy animal of domestication raising, design temperature (22 ± 3) DEG C, relative humidity (50 ±
10) %, lighting hours 12 hours (07:00~19:00) feeding environment performs.
As shown in table 3, each group other point 10,7 groups is always divided into and are tested.In addition to normal group, other wrinkles induce
Group's equal graded irradiation UVB10 weeks.Irradiation group divides control group and positive control group (retinoic acid 2mg/kg, i.p.), other point of dosage
Do not come into operation the collagen water decomposition thing (COL) of general collagen catabolic enzyme (Alcalase) and the collagen of the present invention
Albumen water decomposition thing (CTP) 17mg/kg, 34mg/kg, oral input 14 weeks.Feed is experimental animal solid-state feed
(SAMTAKO BIO KOREA, South Korea), drinking water does not limit.
【Table 3】
The composition of experimental animal
Positive control group with reference to Belinda M methods (The journal of investigative dermatology,
112(3);271-278,1999.), with the vitamin A acid of abdominal cavity investing method input 0.05%.
Ultraviolet lamp is irradiated using the luminous sunlamps of UVB in cage, and light source 302nm, UVB intensity is
0.3mW/cm2Height be irradiated.
Ultraviolet irradiation amount is determined using UV-radiometer.It is every with day interval after mouse is closed in irradiation cage
Week irradiation 3 times, concurrent irradiation [0 week 10 weeks:60mJ/m2(1M.E.D), 1 week:120mJ/m2(2M.E.D), 2~3 weeks:180mJ/m2
(3M.E.D), 4~5 weeks:240mJ/m2(4M.E.D) 5~10 weeks:240mJ/m2(4M.E.D)]
<7-1>Observe the form of wrinkle of skin
Wrinkle of skin state observation is at 5~14 weeks of experimental animal, after carrying out light anaesthesia, is clapped using digital camera
After taking the photograph the photo of rear back surface, with SILFLO (Flexico developments LTD.Tokyo, Japan) silicone rubber impression material
Material makes skin of back wrinkle copy, and uses the state of the other comparative observation wrinkle of trial flock after microscope photographing.
The form for visually observing wrinkle of skin is as shown in figure 12.Observation uses the SILFLO SKH-1 hairless mouses made
The result of skin Plate for coping model, it is thicker to irradiate the wrinkle thickness ratio of UVB control group (C group), and interval is wider, and wrinkle is deep,
Put into P group and the COL 17 of vitamin A acid, 34mg/kg input groups, wrinkle is less compared with C faciations or wrinkle thickness of thin, line
Thinner (Figure 12).
As can be seen here, even if the UVB of irradiation 10 weeks, collagen water decomposition thing of the invention is to SKH-1 hairless mouses
Epidermal keratinocytes play effective effect, are believed to be effectively improved the formation and prevention of wrinkle of skin.
<7-2>Observe skin histology
The skin histology cut is placed on after fixing 24 hours in 10% neutral formalin solution of room temperature, using routine
Method washed, be dehydrated, transparence, infiltration etc. is after process, is cut into slices using FFPE and being made with 4 μ m thicks, and soak
Steep in one evening of Bouin solution, and after use hematoxylin eosin staining, with the collagen in observation by light microscope skin corium
Fiber (collagen fiber).
Moreover, by the skin histology cut be placed in 10% neutral formalin solution it is fixed after, washing, and with 60%~
100% alcohol carries out dewater treatment successively, and blocking using being made after FFPE.Using rotary microtom by it with 5 μ
M thickness is cut into slices, and using after hematoxylin eosin staining, is observed with light microscope (Nikon Co., Tokyo, Japan).
During excessive exposure UVB, epidermis becomes coarse, and normal collagen construction is destroyed, causes the arrangement of collagen not
Rule, elastic fibers are reduced.
Change and the result of loss amount and form of the elastic fibers in dermal layer of the skin are observed, can be in control group (C
Group) in confirm the elastic fibers substantially deformed, but positive control group and COP group, the elastic fibers of CTP group pass through 14 weeks
Sample process after with C faciations are obvious becomes dense (Figure 13).
Moreover, the result of the collagen amount of observation intradermal, the collagenous fibres for only irradiating UVB C group are destroyed, arrange
Irregular, collagen amount also compared with normal group (N group), is inclined in reducing.But carry out the P of vitamin A acid processing
Relatively dense and rule is more presented with C faciations in group, COL group and CTP group.The glue of CTP group particularly compared with COL faciations
Former protein content is more good (Figure 13) with dense degree.
<7-3>Confirm skin histology collagen, collagen catabolic enzyme protein generation (Collagen 1A,
MMP-1)
Skin is excessive to be exposed under UV environment, and MMP-1 can be caused excessively to generate, and active oxygen excess generation, is resisted
Oxidation is destroyed.And the secretion of inflammatory cytokine increases in the presence of keratinocyte, hinders intradermal
Collagen synthesis in fiber subcellular fraction, and promote the activity of catabolic enzyme, form excessive wrinkle.For this relevant people of the present invention
Member puts into general collagen catabolic enzyme (COL group) and the collagen moisture of the present invention to irradiation UVB SKH-1 hairless mouses
After solving thing (CTP group), collagen synthesis factor Collagen 1A and collagen catabolic enzyme are confirmed by Western blotting
The generation of MMP-1 protein.
For analysing protein, after off-test, it is every that the mice skin tissue of collection is put into cell lysis buffer solution
After the other 200 μ L of 20mg, tissue is crushed using homogenizer, and in 800rpm, the centrifugation of progress 10 seconds, only using filtering
Liquid.After the ice hatching that 24 disappear, with 14000rpm, the centrifugation of 20 minutes is carried out under 4 DEG C of environment.Utilize Bradford
Assay2) after quantitative protein, the SDS-PAGE (polyacrylamide gel electrophoresis) of protein is recycled according to size classes.Profit
PVDF (polyvinylidene chloride Polyvinylidene fluoride) is moved to half dry type transmission system (Bio-Rad, USA)
After film, a hour is handled using the confining liquid (5% skim milk, 1 × TBST buffer) containing 5% skim milk.Use 1
× TBST buffer are cleaned 3 times after 10 minutes, after the Collagen 1A, MMP-1, MMP-13 that handle primary antibodies, 4
An evening is reacted under DEG C environment, and is cleaned 3 times after 10 minutes using 1 × TBST buffer herein.Examined using western blot
After test agent box (Abfrontier, WEST SAVE GOLD) produces reaction with film, Chemi-Doc (BIORAD XRS are used
System) equipment observation generation degree, and be compared after being adjusted with GAPDH.
Figure 14 is its result schematic diagram.
Irradiate the collagen synthesis factor Collagen 1A of the UVB C group obvious (p of growing amount<0.05) reduce, but
The Collagen 1A growing amounts put into the group of sample have been lifted.Particularly put into the P group and COL of vitamin A acid
The p of 34, CTP 34 masses<0.05 significant increase (Figure 14 A).
Confirm collagen catabolic enzyme MMP-1 protein generation, it is found that the MMP-1 growing amounts in irradiation UVB C group increase
Add.Opposite, the MMP-1 growing amounts (p in CTP is 17,34 crowds<0.05) significantly reduce, CTP 17,34 can be learnt with this
Group is significantly more outstanding (Figure 14 B) than positive control group and COL group.
Based on the above results, the irradiation of excessive ultraviolet causes the increase of collagen catabolic enzyme, collagen synthesis enzyme
Generation is reduced, and after being handled 14 weeks using the collagen water decomposition thing of the present invention, is compared than general collagen water decomposition thing,
Increase Collagen 1A growing amount, reduce MMP-1 generation, there is significantly anti-wrinkle effect.
<7-4>Confirm the moisturizing of skin histology
When causing dermal tissue insult because of ultraviolet irradiation, the grease of skin and the content of moisture are reduced therewith.This reality
Applying a main purpose is, confirms to irradiate the grease in the skin histology of the mouse of the ultraviolet of 10 weeks and whether moisture subtracts
It is few, and, whether collagen water decomposition thing of the invention can repair the reduction of these greases and moisture.
Put into general collagen water decomposition thing (COL group) and the collagen water decomposition thing (CTP group) 5 of the present invention
In week, after 10 weeks, use the grease and the (Courage- of moisture measurement apparatus Corneometer CM 820 of skin
Hazake, Koln, Germany) carry out the measurement of grease and moisture.In 21.5 ± 2 DEG C of constant temperature and humidity, relative humidity 40
Certain limit measurement moisture is identified in the environment of ± 5%, after stablizing 30 minutes.
Figure 15 is its result schematic diagram.
As shown in figure 15, because between 10 weeks ultraviolet irradiation, can confirm that control (C) group grease and moisture and
The normal control group (N) of ultraviolet is not irradiated compared to significantly reduction.In addition, carry out at collagen water decomposition thing of the present invention
For the fauna of reason compared with normal control faciation, irradiation 5 weeks and 10 weeks is presented higher grease and moisture, and
And such effect increases with the content of collagen water decomposition thing, grease and moisture also together increase.Particularly originally
The skin moisturization of input is than general collagen water decomposition thing (COL in the collagen water decomposition thing (CTP group) of invention
Group) more outstanding (Figure 15 A, B).
<Embodiment 8>
Utilize the improvement skin moisturization of BP collagen water decomposition thing
Guide (health food test method(s) instructs guide, and beauty related functionality is tested, 2004.) is instructed with reference to the food medicine Room,
Such as the content of table 4, each group does not select 10, is always divided into 5 groups and is tested.Normal group (N group) uses Balb-C mouse, skin
Dry the NC/Nga Tnd mouse for the increase transepidermal water discharge commonly used in sample selection moisturizing experiment.To induce dry skin shape
State, with reference to Okawa et al. methods (Dermatol Sci.66 (2):136-43,2012.), 1 week before dissection starts, and will make up
Cotton (2 × 2cm) is soaked in 1:After being placed on back 15 seconds after the acetone and diethyl ether solution of the mixing of 1 ratio, then wiped with distilled water
Same position 30 seconds, prepared in advance for dry skin.
For do not induce dry skin normal control group (Normal group, N group) and, induce and dry skin and only throw
Enter the negative control group (Control group, C group) of solvent, by oral 4 weeks of 0.9% salt solution, positive control group (P group) used
Certification at food and drug safety is obtained, improves dry skin and improves NAG (the N- acetamido glucoses of skin moisture content
Sugar, N-acetyl glucosamine).It is that N-acetyl glucosamine 17mg/kg are orally put into absorb dosage.
It is better than COL34 moistening effect in addition, though the CTP17 in the fact Example 7-4 is low.Therefore, according to reality
The collagen water decomposition thing 17mg/kg (CLT17 group) of the invention of the manufacture of example 4 is applied, with the glue manufactured according to the embodiment 1
Former albumen water decomposition thing 34mg/kg (COL34 group) is oral respectively to be put into 4 weeks.Feed is experimental animal solid-state feed
(SAMTAKO BIO KOREA, South Korea), drinking water does not limit.
【Table 4】
Experimental animal group
<8-1>Measure skin moisture content
The cuticula of the epidermis of health contains 15~20% moisture, and skin is presented when the moisture of epidermis is less than 10%
Dry, it is lackluster and elastic, cause wrinkle to increase.The water that the sense of touch of the soft water profit of skin will be leaned in horny layer of epidermis
Divide and maintain.
The moisture of cuticula is the lipid by being generated on skin, as existing in the sebum film and cuticula of adsorbent
Water soluble ingredient natural moisturizing factor (NMF:Natural Moisture factor) determine, the moisture evaporation of epidermis with
The changes of contents of ceramide and natural moisturizing factor has substantial connection.
To confirm the collagen water decomposition thing 17mg/kg (CTP 17) or disclosed collagen of the present invention
After collagen water decomposition thing 34mg/kg (COL 34) that catabolic enzyme is manufactured is put into 4 weeks, the influence that is brought to skin moisture-keeping
And characteristic, before experiment one week at that time, use (the Courage- of analyzer Corneometer CM 820 of skin moisture content
Hazake, Koln, Germany) position for inducing dry skin is measured.In 21.5 ± 2 DEG C of constant temperature and humidity, relative humidity
Certain limit measurement moisture is identified in the environment of 40 ± 5%, after stablizing 30 minutes.
Figure 16 is its result schematic diagram.
Though maintaining the moisture of the epidermis of the Balb-C mouse of normal group (N group), dry skin is induced
Control group (C group) moisture compared with normal control faciation significantly reduces.In addition, positive control group, CTP 17, COL 34 crowds
There are the effect of increase skin moisture content, wherein CTP 17 best results.
There is more excellent skin moisturization than COL 34mg/kg in the case of CTP inputs 17mg/kg, it can be seen that,
The moistening effect of the higher collagen water decomposition thing of the invention of collagen tripeptide content discloseder collagen egg than
Plain boiled water analyte significant effect.
<8-2>The effect for the pruritus that dry skin triggers
Skin is the carrier for carrying various immune substances, and the part reflected at first to exterior materials.Skin
Wall is injured, reduces water combining power while causing the water loss of hard epidermis to increase, ultimately results in dry skin, skin occurs
Itch.Therefore, after putting into various materials to animal specimen, the effect for relaxing pruitus is evaluated.
Scratch the state that behavior (Scratching behavior) viewing test animal scratched in 10 minutes.Same cluster
Test body be placed in same cage, confirmation scratches number.The continuous action for continuing more than 2 seconds continues the number meter during n seconds
Number is that the of short duration movement counting within n times, 2 seconds is 1 time.
Figure 17 is its result schematic diagram.
After inducing dry skin, the result for the number that scratched within confirming 10 minutes is shown, triggers the control l group (C of xerosis
Group) in p<0.05 attention rank scratch number increase while, respectively put into sample group in the number that scratches substantially subtract
Few (p<0.05).
On the one hand, the alleviation effects of pruritus caused by dry skin are fitst water in CTP 17, in addition to COL 34, than sun
Property control group is more outstanding.
<8-3>The protein recovery effects (Collagen 1A, AQP3, HAS2) of the skin moisture-keeping factor
For analysing protein, after adding cell pyrolysis liquid in skin histology, tissue is destroyed using homogenizer, and use
Filtered fluid is extracted after centrifuge filtering.By Bradford assay to quantification of protein after, perform polyacrylamide gel electricity
Swim SDS-PAGE (Poly acrylamide Gel Electrophoresis).Using half dry type transmission system (Bio-Rad,
USA after) being moved to PVDF (Polyvinylidene fluoride) membrane, Chemi-Doc (BIORAD XRS are used
System) equipment observation generation degree, and be compared after being adjusted with GAPDH.
(i) collagen is the shape for participating in cell, the function point analysis such as differentiation movement and the synthesis of protein, and wound
Vital constituent during mouth recovers.Trigger xerodermia, cause the collagen content in skin to reduce, finally lead
Formation of wrinkle etc. is caused to produce deleterious effect to skin.
(ii) aquaporin -3 (AQP3) plays critically important effect to the aquation (hydration) of skin.Skin is done
Dry, AQP3 generation will be reduced, and had influence on transepidermal water and be lost in (TEWL).Aquaporin present in cell membrane (AQP3)
Increase, will preserve the moisture in skin, eventually become anti-ageing factor (J.Lipid Res.46:2706,2005.).Therefore
One of an important factor for aquaporin -3 (AQP3) present in confirmation cell membrane is the moisture level of confirmation skin
(Biology of the cell.97(7):479-486 2005.).
(iii) glucan (hyaluronic acid, HA) is that macromolecule osamine present in extracellular connection tissue gathers
Sugar, play the protection wall effect for stopping moisture evaporation.With advancing age, the beta-dextran content for making the effect of moisture protective bulkhead is anxious
Play declines.Outside environmental elements middle-ultraviolet lamp maintains glucan to play minus effect skin.Because of this inherent or transient cause Portugal
The reason for reduction of glycan content can cause skin to reduce santal, pachylosis, wrinkle etc..Therefore it is to protect to maintain beta-dextran content
Hold moisture of skin and maintain the secret formula of ruddy complexion skin.Glucan is to continue through hyaluronic acid synthetase (HAS) synthesis.Therefore
HAS gene increases, and the content of the glucan in skin can also rise, the moisturizing to skin, skin elasticity, and wrinkle etc. is asked
Topic has energetically effect.
Therefore, the related personnel of the present invention is by detected by Western blot, to the collagen water decomposition thing of the present invention because
Dry skin and cause the influence of skin moisture-keeping factor reduction to be evaluated.
Figure 18 is its result schematic diagram.
As shown in figure 18, with dry skin is induced, Collagen 1A, AQP3 and HAS content ratio can confirm that just
Normal control group significantly reduces.On the other hand, positive control group, CTP 17 and COL 34 crowds are compared with control group (C group), respectively
The major part of individual albumen quality has been recovered.Wherein CTP 17 has significant skin moisture-keeping factor recovery effects, and input amount is only
COL 34 half, but it is more outstanding than COL 34 effect.
That is, absorptivity is very good inside the collagen water decomposition thing of the invention rich in collagen, even if throwing
It is few to enter amount, can also reach remarkable result.
Collagen water decomposition thing of the invention has outstanding anti-wrinkle effect and skin moisturization as can be seen here, can
Reach effective resisting age of skin and improve the effect of skin elasticity.
【Utilization possibility in industry】
The present invention relates to a kind of collagen water decomposition thing rich in collagen tripeptide and collagen water decomposition thing
Purposes, collagen water decomposition thing of the invention compared with existing collagen water decomposition thing, collagen tripeptide
Content showed increased, human body are preferable to its absorptivity, can effectively prevent baldness, promote hair tonic, improve wrinkle and skin is protected
It is wet etc., there is higher industry to utilize possibility.
Claims (13)
- A kind of 1. collagen water decomposition thing rich in collagen tripeptide, it is characterised in that the collagen water decomposition thing It is to be prepared by following phases,(a) stage being heat-treated to the mixture of fish scale and water;(b) after by centrifuging bacillus subtilis strain nutrient solution, concentration centrifuge gained filtered fluid and using from The stage of the method manufacture collagen catabolic enzyme of sub- exchange chromatography purification;(c) by the collagen catabolic enzyme input described in (a) stage mixture in after, in 25~45 DEG C of Environmental Water Solve the stage of 5~15 hours;Wherein, collagen tripeptide accounts for 20~70wt% of overall moisture solution thing.
- 2. collagen water decomposition thing as claimed in claim 1, it is characterised in that the bacillus subtilis is deposit number KCTC12866BP bacterial strain.
- 3. collagen water decomposition thing as claimed in claim 1, it is characterised in that the ion-exchange chromatography in (b) stage Method uses cation-exchange chromatography, and concentration is 0.1~0.3M sodium chloride (NaCl).
- 4. collagen water decomposition thing as claimed in claim 1, it is characterised in that the ion-exchange chromatography in (b) stage Method uses anion-exchange chromatography, and concentration is 0.09~0.155M sodium chloride (NaCl).
- 5. a kind of Anti-hair loss or the food compositions for promoting hair tonic, it is characterised in that including any described in claim 1-4 Collagen water decomposition thing and active ingredient is used as using the collagen water decomposition thing.
- 6. a kind of Anti-hair loss or the pharmaceutical composition for promoting hair tonic, it is characterised in that including any described in claim 1-4 Collagen water decomposition thing and active ingredient is used as using the collagen water decomposition thing.
- 7. a kind of cosmetic compositions, it is characterised in that including any described collagen water decomposition thing in claim 1-4 And active ingredient is used as using the collagen water decomposition thing.
- It is 8. a kind of for cosmetic compositions that are crease-resistant, improving skin elasticity, prevent skin aging or skin moisture-keeping, its feature Be, including in claim 1-4 any described collagen water decomposition thing and using the collagen water decomposition thing as Active ingredient.
- 9. a kind of exist for food compositions that are crease-resistant, improving skin elasticity, prevent skin aging or skin moisture-keeping, its feature In, including any described collagen water decomposition thing and using the collagen water decomposition thing as having in claim 1-4 Imitate composition.
- 10. the collagen water decomposition thing as described in any in a kind of 1-4 such as claim in manufacture Anti-hair loss or promotes hair tonic to use Purposes in therapeutic agent.
- 11. a kind of Anti-hair loss or the method for promoting hair tonic, it is characterised in that including any in the claim 1-4 by effective dose Described collagen water decomposition thing is put into the individual for needing the composition.
- 12. the collagen water decomposition thing as described in any in a kind of 1-4 such as claim is manufacturing crease-resistant, improvement skin elasticity, Purposes in anti-aging or skin moisture-keeping agent.
- 13. it is a kind of crease-resistant, improve skin elasticity, the method for preventing skin aging or skin moisture-keeping, it is characterised in that including that will have Any described collagen water decomposition thing is put into the individual for needing the composition in the claim 1-4 of effect amount.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2016-0014896 | 2016-02-05 | ||
KR20160014896 | 2016-02-05 | ||
PCT/KR2017/001217 WO2017135754A1 (en) | 2016-02-05 | 2017-02-03 | Collagen hydrolysate containing high content of collagen tripeptide and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107531775A true CN107531775A (en) | 2018-01-02 |
CN107531775B CN107531775B (en) | 2022-01-21 |
Family
ID=59499930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780001018.5A Active CN107531775B (en) | 2016-02-05 | 2017-02-03 | Collagen hydrolysate rich in collagen tripeptide and use of collagen hydrolysate |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR101980361B1 (en) |
CN (1) | CN107531775B (en) |
WO (1) | WO2017135754A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110129393A (en) * | 2019-06-04 | 2019-08-16 | 杭州柏淼生物科技有限公司 | Collagen tripeptide and its preparation process |
TWI737402B (en) * | 2019-07-17 | 2021-08-21 | 大陸商上海利統生化製品有限公司 | Edible composition for promoting hair growth and delaying whitening |
CN116251028A (en) * | 2023-03-23 | 2023-06-13 | 海南华研胶原科技股份有限公司 | Collagen tripeptide compound for after-sun repair and preparation method thereof |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101886123B1 (en) * | 2016-08-17 | 2018-08-07 | (주)진셀팜 | Peptide for improving skin wrinkle, and uses thereof |
KR102322269B1 (en) | 2019-06-28 | 2021-11-05 | 주식회사 리앤씨바이오 | Calcium-collagen peptide chelate complex and method for preparing the same |
KR102236944B1 (en) * | 2020-04-29 | 2021-04-06 | (주)네오크레마 | Functional food composition and cosmetic composition comprising galacto-oligosaccharide, or galacto-oligosaccharide and collagen tripeptides for improving immune function and skin condition |
KR102485612B1 (en) | 2020-06-09 | 2023-01-09 | (주)세울코퍼레이션 | Composition for promoting absorption of collagen and synthesis of collagen |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103232963A (en) * | 2013-05-27 | 2013-08-07 | 天津益丽康生物科技有限公司 | Collagenase producing strain |
CN103243144A (en) * | 2013-05-27 | 2013-08-14 | 天津益丽康生物科技有限公司 | Collagen powder rich in collagen tripeptide and preparation method thereof |
CN104382799A (en) * | 2014-12-01 | 2015-03-04 | 上海汀澜生物科技有限公司 | Skin care product having anti-wrinkle firming and beauty-maintaining moisturizing effects |
CN104523554A (en) * | 2014-11-20 | 2015-04-22 | 彩虹之巅电子商务(上海)有限公司 | Anti-wrinkle moisture-retention skin care product containing bioactive peptide ingredient |
WO2016076647A1 (en) * | 2014-11-13 | 2016-05-19 | 아미코젠주식회사 | Method for preparing collagenase and method for preparing collagen tripeptide using same |
CN107532157A (en) * | 2014-11-13 | 2018-01-02 | 爱美科生物株式公司 | Prepare the method for clostridiopetidase A and prepare the method for collagen tripeptide using it |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100699324B1 (en) * | 2003-02-19 | 2007-03-23 | 나카가와모모키 | Method of producing protein hydrolysates from fish scale |
KR100647033B1 (en) * | 2003-09-02 | 2006-11-17 | 주식회사 젤텍 | Process for preparing sterilized pure water-soluble collagen peptide |
KR101020312B1 (en) * | 2008-04-07 | 2011-03-08 | 주식회사 키토라이프 | Preparation method of collagen peptides from fish scale |
CA2759424C (en) * | 2009-04-28 | 2018-01-02 | Meiji Co., Ltd. | Collagen peptide composition having good ability to enter the blood and food or beverage containing the same |
KR20120071621A (en) * | 2010-12-23 | 2012-07-03 | 김태용 | A anti-aging cosmetic composition containing hydrolysis collagen peptide stabilized in nano-liposome and corn extract |
KR101451971B1 (en) * | 2012-07-26 | 2014-10-23 | 영산홍어(주) | Mass production method of collagen peptide derived from fishskin |
-
2016
- 2016-12-23 KR KR1020160178299A patent/KR101980361B1/en active IP Right Grant
-
2017
- 2017-02-03 WO PCT/KR2017/001217 patent/WO2017135754A1/en active Application Filing
- 2017-02-03 CN CN201780001018.5A patent/CN107531775B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103232963A (en) * | 2013-05-27 | 2013-08-07 | 天津益丽康生物科技有限公司 | Collagenase producing strain |
CN103243144A (en) * | 2013-05-27 | 2013-08-14 | 天津益丽康生物科技有限公司 | Collagen powder rich in collagen tripeptide and preparation method thereof |
WO2016076647A1 (en) * | 2014-11-13 | 2016-05-19 | 아미코젠주식회사 | Method for preparing collagenase and method for preparing collagen tripeptide using same |
CN107532157A (en) * | 2014-11-13 | 2018-01-02 | 爱美科生物株式公司 | Prepare the method for clostridiopetidase A and prepare the method for collagen tripeptide using it |
CN104523554A (en) * | 2014-11-20 | 2015-04-22 | 彩虹之巅电子商务(上海)有限公司 | Anti-wrinkle moisture-retention skin care product containing bioactive peptide ingredient |
CN104382799A (en) * | 2014-12-01 | 2015-03-04 | 上海汀澜生物科技有限公司 | Skin care product having anti-wrinkle firming and beauty-maintaining moisturizing effects |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110129393A (en) * | 2019-06-04 | 2019-08-16 | 杭州柏淼生物科技有限公司 | Collagen tripeptide and its preparation process |
CN110129393B (en) * | 2019-06-04 | 2020-12-15 | 广州市爱百伊生物技术有限公司 | Collagen tripeptide and preparation process thereof |
TWI737402B (en) * | 2019-07-17 | 2021-08-21 | 大陸商上海利統生化製品有限公司 | Edible composition for promoting hair growth and delaying whitening |
CN116251028A (en) * | 2023-03-23 | 2023-06-13 | 海南华研胶原科技股份有限公司 | Collagen tripeptide compound for after-sun repair and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR101980361B1 (en) | 2019-08-28 |
KR20170093694A (en) | 2017-08-16 |
CN107531775B (en) | 2022-01-21 |
WO2017135754A1 (en) | 2017-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107531775A (en) | The purposes of collagen water decomposition thing and collagen water decomposition thing rich in collagen tripeptide | |
US20120128607A1 (en) | Extract of whole seeds of morninga sp, and use thereof in cosmetic and/or dermatological compositions | |
US10675233B2 (en) | Compositions containing natural extracts and use thereof for skin and hair | |
CN109152727B (en) | Peptides and sugar hydrolysates of cocoa beans, cosmetic compositions containing them and cosmetic use of the cosmetic compositions | |
KR20120012904A (en) | Cosmetic compositions for improving breast augmentation or skin elasticity | |
CN114344188A (en) | Hair loss prevention and hair growth promoting composition and preparation method thereof | |
KR101697152B1 (en) | Manufacturing method of cosmetic material having an anti-aging effect using mucin from eel skin | |
CN111265441A (en) | Composition capable of enhancing skin night repair and regeneration capacity and application thereof | |
CN106562904A (en) | Facial mask containing passion fruit extract and preparation method of facial mask | |
CN110403890A (en) | The composition for beautifying skin including sturgeon Egg extracts and sturgeon amniotic fluid extract | |
JP2011190217A (en) | Human epidermal cell growth promoter, and skin care composition for external use and cosmetic each containing the same | |
KR20190001105A (en) | Cosmetic composition for scalp protection and hair improvement containing ginsenoside F5 derive from aerial part of hydroponic ginseng and gold sericin derive from golden silkworm | |
JP6173362B2 (en) | Skin barrier function improving agent, intercellular adhesion structure formation promoter, tight junction formation promoter, TRPV4 activator, intracellular Ca concentration increase promoter and sebum production promoter | |
KR101618726B1 (en) | Method for making protein from Pollock skin | |
KR20020084619A (en) | Cosmetic composition containing phellinus linteus extract and vitis vinifera l. fermented solution and having anti-wrinkle effect | |
JP2006241130A (en) | Function of ameliorating collagen fiber formation and wrinkle and flabbiness of human body skin to enhance lifting effect through using polymer component of water-soluble polysaccharide in bracket fungus of the genus fomes | |
KR101997231B1 (en) | Cosmetic composition containing enzyme-treated honey extract | |
KR101609217B1 (en) | Method for making glycoprotein from jelly fish and cosmetics containing the same | |
JP2009234976A (en) | Cell activator and external preparation for skin for antiaging | |
CN105636653A (en) | Cosmetic or dermatological use of an extract of tapirira guianensis | |
KR102267099B1 (en) | Cosmetic composition with excellent skin elasticity and wrinkle improvement | |
KR102523796B1 (en) | Sebum increase agent and hyaluronic acid production promoter | |
KR102543076B1 (en) | Composition comprising DNA components for suppressing specific gene expression, controlling epigenetic mutation, and improving skin condition | |
KR102499607B1 (en) | Rejuvenating eye serum type cosmetic composition and manufacturing method thereof | |
JP7408269B2 (en) | Melanosome degradation promoter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |